These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35286436)

  • 21. Organic anxiety in a woman with breast cancer receiving denosumab.
    Lin KF; Chen KH; Huang WL
    Gen Hosp Psychiatry; 2015; 37(2):192.e7-8. PubMed ID: 25772947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Denosumab for central giant cell granuloma in an Australian tertiary paediatric centre.
    Vanderniet JA; Wall CL; Mullins A; London K; Lim L; Hibbert S; Briody J; Padhye B; Poon M; Biggin A; Dalla-Pozza L; Munns CF
    Bone; 2022 Jun; 159():116395. PubMed ID: 35331976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controversies in the use of new bone-modifying therapies in multiple myeloma.
    Terpos E; Ntanasis-Stathopoulos I
    Br J Haematol; 2021 Jun; 193(6):1034-1043. PubMed ID: 33249579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Denosumab: a new agent in the management of hypercalcemia of malignancy.
    Thosani S; Hu MI
    Future Oncol; 2015; 11(21):2865-71. PubMed ID: 26403973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Denosumab-Associated Severe Hypocalcemia in a Patient With Chronic Kidney Disease.
    Salim SA; Nair LR; Thomas L; Garla V; Palabindala V; Agarwal M; Fülöp T
    Am J Med Sci; 2018 May; 355(5):506-509. PubMed ID: 29753381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypercalcemia and hypercalciuria during denosumab treatment in children with osteogenesis imperfecta type VI.
    Trejo P; Rauch F; Ward L
    J Musculoskelet Neuronal Interact; 2018 Mar; 18(1):76-80. PubMed ID: 29504582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical tibial fracture in breast cancer patient with bone metastasis receiving denosumab therapy: a case report and review of the literature.
    Yanagisawa Y; Suzuki H; Gamada H; Yamazaki M
    J Med Case Rep; 2023 Jun; 17(1):257. PubMed ID: 37340320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Humoral Hypercalcemia in a Patient with Cholangiocellular Carcinoma - Effective Therapy with Denosumab.
    Harsch IA; Konturek PC
    Am J Case Rep; 2019 Sep; 20():1325-1330. PubMed ID: 31492829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Denosumab in a pediatric kidney transplant recipient with late, resistant hypercalcemia secondary to Pneumocystis jirovecii pneumonia.
    Beale F; Gkiourtzis N; Koneru S; O'Brien C; Lalayiannis AD
    Pediatr Nephrol; 2024 Aug; 39(8):2355-2358. PubMed ID: 38277030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab.
    Loyson T; Van Cann T; Schöffski P; Clement PM; Bechter O; Spriet I; Coropciuc R; Politis C; Vandeweyer RO; Schoenaers J; Dumez H; Berteloot P; Neven P; Nackaerts K; Woei-A-Jin FJSH; Punie K; Wildiers H; Beuselinck B
    Acta Clin Belg; 2018 Apr; 73(2):100-109. PubMed ID: 28693379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bisphosphonates and other bone agents for breast cancer.
    Wong MH; Stockler MR; Pavlakis N
    Cochrane Database Syst Rev; 2012 Feb; (2):CD003474. PubMed ID: 22336790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Denosumab treatment for refractory hypercalcemia in a hemodialysis patient with tertiary hyperparathyroidism.
    Zhang P; Yu Y; Gao Y; Yuan G; Zhang J; Wang W
    Hemodial Int; 2023 Apr; 27(2):E23-E28. PubMed ID: 36719850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case Report: Prophylactic Plate Fixation for Incomplete Atypical Ulnar Fractures Resulting From the Use of Denosumab for Bone Metastases.
    Murai A; Tada K; Nakajima T; Akahane M; Matsuta M; Nakamura Y; Tsuchiya H
    Front Endocrinol (Lausanne); 2021; 12():798653. PubMed ID: 35069445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Denosumab for the Treatment of Hypercalcemia in a Patient With Parathyroid Carcinoma: A Case Report.
    Roukain A; Alwan H; Bongiovanni M; Sykiotis GP; Kopp PA
    Front Endocrinol (Lausanne); 2021; 12():794988. PubMed ID: 35173680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe and prolonged hypocalcemia after a single dose of denosumab for metastatic breast cancer with diffuse bone involvement without prior calcium/vitamin D supplementations.
    Uhm SJ; Hall JA; Herrington JD
    J Oncol Pharm Pract; 2021 Jul; 27(5):1287-1290. PubMed ID: 33081580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Denosumab versus intravenous bisphosphonate use for hypercalcemia in multiple myeloma.
    Lei MM; Tavares E; Buzgo E; Lou U; Raje N; Yee AJ
    Leuk Lymphoma; 2022 Dec; 63(13):3249-3252. PubMed ID: 36036363
    [No Abstract]   [Full Text] [Related]  

  • 37. Ibandronate, an experimental intravenous bisphosphonate for osteoporosis, bone metastases, and hypercalcemia of malignancy.
    Guay DR
    Pharmacotherapy; 2006 May; 26(5):655-73. PubMed ID: 16637795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hypercalcemia: a practical review].
    Barbry A; Masserey-Bonvin V; Petignat PA
    Rev Med Suisse; 2024 Feb; 20(860):300-304. PubMed ID: 38323765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer.
    Stopeck AT; Fizazi K; Body JJ; Brown JE; Carducci M; Diel I; Fujiwara Y; Martín M; Paterson A; Tonkin K; Shore N; Sieber P; Kueppers F; Karsh L; Yardley D; Wang H; Maniar T; Arellano J; Braun A
    Support Care Cancer; 2016 Jan; 24(1):447-455. PubMed ID: 26335402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sixty spontaneous vertebral fractures after denosumab discontinuation in 15 women with early-stage breast cancer under aromatase inhibitors.
    Gonzalez-Rodriguez E; Aubry-Rozier B; Stoll D; Zaman K; Lamy O
    Breast Cancer Res Treat; 2020 Jan; 179(1):153-159. PubMed ID: 31598815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.